Study on Vaginal Microecology and Cervical Local Immune Function in Patients With Uterine Fibroids of Childbearing Age
NCT ID: NCT06055114
Last Updated: 2023-09-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
300 participants
OBSERVATIONAL
2023-10-09
2026-10-09
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Study on the Pathogenesis and Determinants of Intravenous Leiomyomatosis
NCT06773819
A Cohort Study for the Following up of Conization
NCT03961178
HPV Infection and Genital Microecology of Childbearing-age Female in China: A Cohort and Multicenter Study
NCT04694495
A Cohort Study of Uterine Malignancies
NCT05635123
Characteristics of Vaginal and Intestinal Microbiota and Cervical HPV Infection
NCT05003505
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
study group
Age 20-49 years old; Premenopausal; Clinical diagnosis of uterine myoma; Cervical liquid-based cytology and human papillomavirus typing test are negative.
Microscopic examination of vaginal discharge
Using gram-stained smears to detect vaginal secretions, and then the concentration and diversity of bacterial flora are observed using a microscope.
Healthy control group
Age 20-49 years old; Premenopausal; Uterine B-ultrasonography is normal; Cervical liquid-based cytology and human papillomavirus typing test are negative; No vaginal infection.
Microscopic examination of vaginal discharge
Using gram-stained smears to detect vaginal secretions, and then the concentration and diversity of bacterial flora are observed using a microscope.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Microscopic examination of vaginal discharge
Using gram-stained smears to detect vaginal secretions, and then the concentration and diversity of bacterial flora are observed using a microscope.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Premenopausal
* Clinical diagnosis of uterine myoma
* Cervical liquid-based cytology and human papillomavirus typing test are negative
Healthy control group:
* Age 20-49 years old
* Premenopausal
* Uterine B-ultrasonography is normal
* Cervical liquid-based cytology and human papillomavirus typing test are negative
* No vaginal infection
Exclusion Criteria
* Sex, vaginal irrigation or applied medicine 3 days before the vaginal discharge sampling
* Pregnant, lactating or menstruating women
* Uterus and uterine adnexa have other lesions
* Used antibiotics, hormones, immunosuppressants and regulators within 1 month
* Sex, vaginal irrigation or applied medicine 3 days before the vaginal discharge sampling
* Pregnant, lactating or menstruating women
20 Years
49 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Lin Yuan
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Lin Yuan
technologist in charge
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lin Yuan, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
Qianfoshan Hospital
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
References
Explore related publications, articles, or registry entries linked to this study.
Yang Q, Ciebiera M, Bariani MV, Ali M, Elkafas H, Boyer TG, Al-Hendy A. Comprehensive Review of Uterine Fibroids: Developmental Origin, Pathogenesis, and Treatment. Endocr Rev. 2022 Jul 13;43(4):678-719. doi: 10.1210/endrev/bnab039.
El Andaloussi A, Chaudhry Z, Al-Hendy A, Ismail N. Uterine Fibroids: Bridging Genomic Defects and Chronic Inflammation. Semin Reprod Med. 2017 Nov;35(6):494-498. doi: 10.1055/s-0037-1607240. Epub 2017 Nov 3. No abstract available.
Zannotti A, Greco S, Pellegrino P, Giantomassi F, Delli Carpini G, Goteri G, Ciavattini A, Ciarmela P. Macrophages and Immune Responses in Uterine Fibroids. Cells. 2021 Apr 22;10(5):982. doi: 10.3390/cells10050982.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
qfsjyk15853128210
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.